dx.advamed.orgAdvaMedDx - AdvaMed

dx.advamed.org Profile

Dx.advamed.org is a subdomain of advamed.org, which was created on 1999-05-05,making it 25 years ago. It has several subdomains, such as careers.advamed.org myaccount.advamed.org , among others.

Description:AdvaMedDx promotes innovation and expanded access to quality...

Discover dx.advamed.org website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

dx.advamed.org Information

HomePage size: 146.327 KB
Page Load Time: 0.476583 Seconds
Website IP Address: 141.193.213.20

dx.advamed.org Similar Website

AdvaMed |
myaccount.advamed.org

dx.advamed.org PopUrls

AdvaMed NIST CSF RFI Response
http://dx.advamed.org/sites/default/files/resource/comments_on_nist_framework_for_improving_critical_infrastructure_cybersecurity.pdf
Repeal the Medical Device Tax
https://dx.advamed.org/sites/default/files/resource/repeal_the_device_tax_infographic_2017.pdf
CLINICAL LABORATORY COALITION
https://dx.advamed.org/sites/dx.advamed.org/files/resource/CLC%20Letter%20to%20House%20Leadership%20CFLS%20Feb%202014.pdf
THE ROLE OF DIAGNOSTIC TESTS IN ANTIBIOTIC ...
https://dx.advamed.org/sites/dx.advamed.org/files/resource/The%20Role%20of%20Diagnostic%20Tests%20in%20Antibiotic%20Resistance111215-links.pdf
The Value of Advancing Cancer Treatment and Care CANCER DIAGNOSTICS
https://dx.advamed.org/wp-content/uploads/2019/05/from-test-to-treatment-value-cancer-diagnostics-fact-sheet.pdf
ADVAMED CODE OF ETHICS
https://dx.advamed.org/wp-content/uploads/2023/06/2023-AdvaMed-Code-of-Ethics.pdf
A Framework for Comprehensive Assessment of Medical Technologies
https://dx.advamed.org/wp-content/uploads/2023/06/framework-for-comprehensive-assessment-of-medical-technologies-report-long.pdf
From Test to Treatment The Value of Diagnostic Tests in WOMEN’S HEALTH
https://dx.advamed.org/wp-content/uploads/2019/07/test-treatment-value-diagnostics-tests-womens-health-fact-sheet_0.pdf
Understanding Evidence on the Value of Medical Technologies
https://dx.advamed.org/wp-content/uploads/2021/11/Understanding-Evidence-Value-Medical-Technologies-May-2017.pdf
Approaches to Increasing Diversity in Clinical Research and Addressing ...
https://dx.advamed.org/wp-content/uploads/2022/05/Approaches-to-Increasing-Diversity-in-Clinical-Research-and-Addressing-Health-Inequities-May2022.pdf
The Value of From Test to Treatment POINT-OF-CARE Diagnostic Testing
https://dx.advamed.org/wp-content/uploads/2018/11/test-to-treatment-point-of-care-fact-sheet.pdf
From Test to Treatment The Value of Diagnostics in Enabling ...
https://dx.advamed.org/wp-content/uploads/2019/05/from-test-to-treatment-value-of-diagnostics-enabling-personalized-medicine.pdf
The Right Way to Repair Life-saving Medical Technology
https://dx.advamed.org/wp-content/uploads/2022/05/The-Right-Way-to-Repair-Life-Saving-Medical-Technology.pdf

dx.advamed.org Httpheader

Date: Tue, 14 May 2024 20:21:14 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Vary: Accept-Encoding, Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
x-powered-by: WP Engine
Last-Modified: Fri, 18 Nov 2022 10:19:52 GMT
Link: https://www.advamed.org/?p=116; rel=shortlink
X-Cacheable: YES:15552000.000
Cache-Control: max-age=15552000, must-revalidate
X-Cache: HIT: 717
X-Cache-Group: normal
CF-Cache-Status: DYNAMIC
Server: cloudflare
CF-RAY: 883d97ec0f5defb4-PDX
alt-svc: h3=":443"; ma=86400

dx.advamed.org Meta Info

charset="utf-8"/
content="ie=edge" http-equiv="x-ua-compatible"/
content="width=device-width, initial-scale=1" name="viewport"/
content="index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1" name="robots"
content="AdvaMedDx promotes innovation and expanded access to quality testing." name="description"
content="en_US" property="og:locale"
content="article" property="og:type"/
content="AdvaMedDx - AdvaMed" property="og:title"/
content="AdvaMedDx promotes innovation and expanded access to quality testing." property="og:description"/
content="https://www.advamed.org/advameddx/" property="og:url"/
content="AdvaMed" property="og:site_name"/
content="2022-11-18T15:19:52+00:00" property="article:modified_time"/
content="https://www.advamed.org/wp-content/uploads/2021/03/header-home.jpg" property="og:image"/
content="1360" property="og:image:width"/
content="656" property="og:image:height"/
content="image/jpeg" property="og:image:type"/
content="summary_large_image" name="twitter:card"/
content="Site Kit by Google 1.124.0" name="generator"/
content="zcsq1fana8sj9ky97fwextb3352wq9" name="facebook-domain-verification"/
content="https://www.advamed.org/wp-content/uploads/2021/05/cropped-AdvaMed_A_color-270x270.png" name="msapplication-TileImage"/

dx.advamed.org Ip Information

Ip Country: United States
Latitude: 37.751
Longitude: -97.822

dx.advamed.org Html To Plain Text

AdvaMed Our Work Key Issues Policy Areas Sectors Industry Updates Research & Policy Papers Medtech POV with Scott Whitaker Medtech POV Blog Press Releases Join Member Center Committees & Working Groups Resource Library Medtech Career Center Events All Events In Person Online Open Search Open Menu Login AdvaMedDx AdvaMedDx promotes innovation and expanded access to quality testing. Share this page on Twitter Share this page on Facebook Share this page on LinkedIn Email a link to this page AdvaMedDx and the Value of Diagnostics AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed), represents over 70 manufacturers of innovative in vitro diagnostic (IVD) tests in the U.S. and abroad. AdvaMedDx seeks to advance policy to promote innovation and expand access to quality testing. Across the health care delivery system, diagnostic tests are critical for the day-to-day evidence-based care of all patients by enabling early detection of disease, aiding in the determination of the most appropriate clinical pathway for patient care, and increasingly supporting the practice of precision or personalized medicine to improve the health and health care of all patients. Join Us AdvaMedDx Members Our members represent the world’s leading diagnostics manufacturers alongside the next generation of companies developing innovative diagnostic tests and technologies in the U.S. and abroad. All Dx Members Diagnostics Regulatory Reform AdvaMedDx supports the modernization of the regulatory framework for all clinical diagnostic tests to foster innovation, embrace scientific advances, and ensure swift access to accurate and reliable tests for all patients. Learn more Coverage & Payment Diagnostic Tests Coding, Coverage, and Payment Diagnostic tests provide vital information in the management and care of patients. Appropriate coding, coverage, and payment policies for diagnostic tests are crucial to ensuring these products and services are accessible to the patients who need them. Learn More COVID-19 Diagnostics & COVID-19 Diagnostics manufacturers are delivering millions of COVID-19 tests across the U.S. and globally each week. Testing is an essential tool to our pandemic response and recovery. Learn More AdvaMedDx Partners AdvaMedDx collaborates with diagnostics associations across the country and around the world. All Dx Partners Related Content Resource / Diagnostics From Test To Treatment: The Value Of Diagnostics November 14, 2019 AdvaMedDx Test to Treatment fact sheets and social media-ready value facts communicate the value of diagnostics. News / Diagnostics / Government & Legislative Affairs / VALID Act In Congressional Testimony, AdvaMed Urges Passage of Diagnostic Regulatory Reform March 21, 2024 Today, Zach Rothstein, Executive Director of AdvaMedDx, testified before the House Energy and Commerce Committee, Subcommittee on Health during a hearing on diagnostic test regulation and FDA’s proposed laboratory developed test (LDT) rule. Diagnostics / Digital Health / Health Equity American Heart Month This February, AdvaMed is working with member companies and our global partners to raise awareness and highlight the ways medical technology helps those living with cardiovascular disease live healthier, happier lives. News / Diagnostics / Government & Legislative Affairs / VALID Act In Comments to FDA, AdvaMed Maintains Support of Agency’s Authority to Regulate LDTs December 12, 2023 Today, AdvaMedDx submitted comments in response to the Food and Drug Administration’s Proposed Rule: Medical Devices; Laboratory Developed Tests. AdvaMedDx is a division of AdvaMed representing companies that develop in vitro diagnostic (IVD) tests. News / Diagnostics AdvaMed Calls for Reauthorization of AIDS Relief Program November 15, 2023 Today, AdvaMedDx, a division of AdvaMed representing manufacturers of innovative in vitro diagnostic tests, sent a letter urging Congressional leaders to prioritize the reauthorization of the President’s Emergency Plan for AIDS Relief (PEPFAR) program. PEPFAR funding lapsed at the end of the fiscal year 2023. News / Diagnostics AdvaMed Statement on Proposed Laboratory Developed Test Rule September 29, 2023 AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker and Zach Rothstein, Executive Director of AdvaMedDx, on FDA’s recently proposed LDT rule. Event / Diagnostics Dx Summit October 11, 2023 The Dx Summit convenes leaders from the IVD and clinical diagnostic lab community to explore the most significant policies, technologies, and market shifts in the industry. News / Diagnostics / Digital Health New AdvaMed, Deloitte Research Defines Medtech’s Value in Health Care Ecosystem July 25, 2023 Today, AdvaMed, the MedTech Association, released updated reports, in collaboration with Deloitte on frameworks for the comprehensive assessment of medical technologies and diagnostic tests. These seminal reports had been developed to help key stakeholders—payers, providers, health technology assessment bodies, patient advocates, and medtech companies – to assess the value of medical technologies in an emerging value-based care world. View All Become a Member As an AdvaMedDx member, you have the opportunity to shape the future of the industry with like-minded peers. Join AdvaMedDx AdvaMed Stay up to date with AdvaMed. Subscribe for Updates Join Member Center Industry Updates Contact FAQs Events Careers The Story of Medtech The Medtech Conference Because Every Moment Matters Copyright 2024 AdvaMed Sitemap Terms of Use Privacy Policy Accessibility Statement 中文 youtube linkedin facebook X medium instagram Menu Our Work Our Work Key Issues Policy Areas Sectors Industry Updates Industry Updates Research & Policy Papers Medtech POV with Scott Whitaker Medtech POV Blog Press Releases Join Member Center Member Center Committees & Working Groups Resource Library Medtech Career Center Events Events All Events In Person Online Login About AdvaMed About AdvaMed Our Leadership Initiatives Jobs at AdvaMed Contact Us Membership & Join Membership & Join Membership Directory Associate Membership Directory Membership Application Lifetime Achievement Award Medical Device Industry Facts Medical Device Industry Facts Safety & Quality Job Creation AdvaMed Accel AdvaMed Accel Accel Member Directory Partnerships and Opportunities AdvaMedDx AdvaMedDx AdvaMedDX Members AdvaMedDx Resources Join AdvaMedDX AdvaMed Digital Health Tech AdvaMed Digital Health Tech AdvaMed Digital Health Tech Members AdvaMed Medical Imaging AdvaMed Medical Imaging AdvaMed Imaging Members Search...

dx.advamed.org Whois

Domain Name: advamed.org Registry Domain ID: a619eb4b748a4298acd078220ee00f7a-LROR Registrar WHOIS Server: http://whois.godaddy.com Registrar URL: http://www.whois.godaddy.com Updated Date: 2024-05-06T12:26:57Z Creation Date: 1999-05-05T08:16:32Z Registry Expiry Date: 2026-05-05T08:14:52Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: +1.4806242505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Registrant Organization: Domains By Proxy, LLC Registrant State/Province: Arizona Registrant Country: US Name Server: gabe.ns.cloudflare.com Name Server: surina.ns.cloudflare.com DNSSEC: unsigned >>> Last update of WHOIS database: 2024-05-17T19:26:59Z <<<